SNAP29 inhibitors constitute a specialized class of chemical compounds designed to target the SNAP29 (Soluble NSF Attachment Protein 29) protein. SNAP29 is an essential component of the cellular machinery involved in intracellular membrane trafficking and vesicle fusion processes. It is part of the SNARE (Soluble NSF Attachment Protein Receptor) complex, which plays a crucial role in mediating the fusion of vesicles with their target membranes. Specifically, SNAP29 participates in the fusion of vesicles found in the Golgi apparatus and endoplasmic reticulum with various cellular membranes, including the plasma membrane and organelle membranes. This fusion process is fundamental for the transport of proteins, lipids, and other cellular cargo to their appropriate destinations within the cell.
Inhibitors of SNAP29 are designed to interact with this protein and disrupt its involvement in the SNARE complex and vesicle fusion. These inhibitors may operate through various mechanisms, such as binding to specific domains of SNAP29 or altering its conformation. By inhibiting SNAP29, these compounds can interfere with the precise regulation of vesicle trafficking, leading to disruptions in cellular secretion and membrane transport processes. Research on SNAP29 inhibitors is primarily focused on understanding the molecular mechanisms by which SNAP29 contributes to intracellular membrane fusion and trafficking, providing insights into the intricacies of cellular organization and homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
A diterpene triepoxide that can inhibit the expression of various genes, possibly including SNAP29, by affecting transcriptional activity. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
A naturally occurring product that can inhibit protein synthesis, potentially leading to reduced SNAP29 expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
A steroid hormone that, through its receptor interactions, may alter the transcription of certain genes, potentially including SNAP29. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
A synthetic glucocorticoid that acts as a transcription modulator, potentially influencing SNAP29 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that could affect a range of signaling pathways, potentially altering the expression of genes like SNAP29. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that could influence inflammatory signaling pathways and potentially alter SNAP29 gene expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An anthrapyrazolone inhibitor of JNK, which may modulate transcription factors and affect SNAP29 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can affect cellular growth signals, potentially downregulating SNAP29 expression as part of a global response. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
An HDAC inhibitor that can lead to chromatin remodeling and potentially influence SNAP29 gene expression. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
An MDM2 antagonist that can stabilize p53 and might indirectly downregulate SNAP29 expression through p53-mediated pathways. |